GORE® CARDIOFORM ASD occluder thrombus in a patient of rheumatoid arthritis occurred three days after deployment
A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully d...
Saved in:
Published in | International journal of cardiology congenital heart disease Vol. 21; p. 100600 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.09.2025
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis. |
---|---|
AbstractList | AbstractA 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis. A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis. A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis.A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis. |
ArticleNumber | 100600 |
Author | Shigemitsu, Yusuke Nakagawa, Naomi Okamoto, Kengo |
Author_xml | – sequence: 1 givenname: Naomi orcidid: 0000-0002-6357-7582 surname: Nakagawa fullname: Nakagawa, Naomi email: polonekogorogoro@dream.com – sequence: 2 givenname: Yusuke surname: Shigemitsu fullname: Shigemitsu, Yusuke – sequence: 3 givenname: Kengo surname: Okamoto fullname: Okamoto, Kengo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40698378$$D View this record in MEDLINE/PubMed |
BookMark | eNqVks1u3CAUha0qVZOmeYOqYtnNpIANY6Sq1Wjy05FSjTTJHmG4ZHBtMwE70rxUHqJPVlynUbKoqq5AcM534d7zNjvofAdZ9p7gU4IJ_1SfulrrrTmlmLJ0hDnGr7IjyjmfcV6yg2f7w-wkxhpjTMskZORNdlhgLsp8Xh5ld5frzfnPB7RcbM5W64v15jtaXJ8hr3UzGAio3wbfVkNErkMK7VTvoOuRtyhsYWhV751BKiSV610cbUMIYEYbADJqH5GyfeIY2DV-3ybzu-y1VU2Ek8f1OLu5OL9ZfptdrS9Xy8XVTLNS9DOllBGcWsP4nFGtS1twVQIlRGuBCcXVnKrCCFOAVZXNBbWckIqknS1pkR9nqwlrvKrlLrhWhb30ysnfBz7cyvRupxuQXAMzzAph1LwoTVUxxgrCheEcFDMisb5OrN1QtWB0-kVQzQvoy5vObeWtv5eEpp6TokyEj4-E4O8GiL1sXdTQNKoDP0SZ05wWIk1nlH54Xuypyp-ZJUExCXTwMQawTxKC5ZgOWcspHXJMh5zSkWxfJhukpt87CDLqNEwNxgXQfWqL-1-AblzntGp-wB5i7YfQpYFKIiOVWF6PARzzR1nKXs7HNn7-O-Df9X8Bv93uJg |
Cites_doi | 10.1007/s10067-014-2492-7 10.1136/annrheumdis-2013-203380 10.1002/ccd.31002 10.1002/ccd.30067 10.1016/0090-1229(92)90008-C 10.1136/annrheumdis-2020-218419 10.1016/j.jacc.2003.10.030 10.1002/ccd.24875 10.1002/ccd.28728 |
ContentType | Journal Article |
Copyright | 2025 The Authors The Authors 2025 The Authors. 2025 The Authors 2025 |
Copyright_xml | – notice: 2025 The Authors – notice: The Authors – notice: 2025 The Authors. – notice: 2025 The Authors 2025 |
DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1016/j.ijcchd.2025.100600 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2666-6685 |
EndPage | 100600 |
ExternalDocumentID | oai_doaj_org_article_6ce5d5f99da748dbb5554169d66ea5d9 PMC12281148 40698378 10_1016_j_ijcchd_2025_100600 S2666668525000369 1_s2_0_S2666668525000369 |
Genre | Journal Article Case Reports |
GroupedDBID | .1- .FO 0R~ 1P~ AAEDW AALRI AAXUO AAYWO ACVFH ADCNI ADVLN AEUPX AFJKZ AFPUW AFRHN AIGII AITUG AJUYK AKBMS AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP EBS FDB GROUPED_DOAJ M~E OK1 ROL RPM Z5R AFCTW 6I. AAFTH AAYXX CITATION NPM 7X8 5PM |
ID | FETCH-LOGICAL-c589t-aaad962fd56752cc8f46a8e211cc90120b72a4d9d4efabf392f611b1f39f8243 |
IEDL.DBID | DOA |
ISSN | 2666-6685 |
IngestDate | Wed Aug 27 00:48:05 EDT 2025 Thu Aug 21 18:25:38 EDT 2025 Thu Jul 24 01:49:10 EDT 2025 Sat Jul 26 01:47:05 EDT 2025 Wed Jul 16 16:47:54 EDT 2025 Sat Aug 16 17:01:18 EDT 2025 Fri Aug 08 06:00:36 EDT 2025 Tue Aug 26 16:32:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Thrombus formation Atrial septal defect GORE cardioform ASD occluder Congenital heart disease Rheumatoid arthritis |
Language | English |
License | This is an open access article under the CC BY-NC license. 2025 The Authors. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c589t-aaad962fd56752cc8f46a8e211cc90120b72a4d9d4efabf392f611b1f39f8243 |
Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ORCID | 0000-0002-6357-7582 |
OpenAccessLink | https://doaj.org/article/6ce5d5f99da748dbb5554169d66ea5d9 |
PMID | 40698378 |
PQID | 3232490058 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6ce5d5f99da748dbb5554169d66ea5d9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12281148 proquest_miscellaneous_3232490058 pubmed_primary_40698378 crossref_primary_10_1016_j_ijcchd_2025_100600 elsevier_sciencedirect_doi_10_1016_j_ijcchd_2025_100600 elsevier_clinicalkeyesjournals_1_s2_0_S2666668525000369 elsevier_clinicalkey_doi_10_1016_j_ijcchd_2025_100600 |
PublicationCentury | 2000 |
PublicationDate | 2025-09-01 |
PublicationDateYYYYMMDD | 2025-09-01 |
PublicationDate_xml | – month: 09 year: 2025 text: 2025-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | International journal of cardiology congenital heart disease |
PublicationTitleAlternate | Int J Cardiol Congenit Heart Dis |
PublicationYear | 2025 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Oliva, Giugno, Moroni, Sturla, Piazza, Saracino, Micheletti, d'Aiello, Reali, Chessa, Carminati (bib5) 2024 Apr; 103 Abaci, Unlu, Alsancak (bib1) 2013; 82 Mameli, Barcellona, Marongiu (bib9) 2009; 27 Aquino, Muniz, Laufer (bib3) 2022; 99 Krumsdorf, Ostermayer, Billinger (bib2) 2004; 43 Molander, Bower, Frisell (bib10) 2021; 80 Chung, Peng, Lin (bib6) 2014; 73 Ungprasert, Srivali, Spanuchart (bib7) 2014; 33 Sommer, Love, Paolillo (bib4) 2020; 95 Zacharski, Brown, Memoli (bib8) 1992; 63 Aquino (10.1016/j.ijcchd.2025.100600_bib3) 2022; 99 Sommer (10.1016/j.ijcchd.2025.100600_bib4) 2020; 95 Chung (10.1016/j.ijcchd.2025.100600_bib6) 2014; 73 Zacharski (10.1016/j.ijcchd.2025.100600_bib8) 1992; 63 Oliva (10.1016/j.ijcchd.2025.100600_bib5) 2024; 103 Abaci (10.1016/j.ijcchd.2025.100600_bib1) 2013; 82 Mameli (10.1016/j.ijcchd.2025.100600_bib9) 2009; 27 Krumsdorf (10.1016/j.ijcchd.2025.100600_bib2) 2004; 43 Ungprasert (10.1016/j.ijcchd.2025.100600_bib7) 2014; 33 Molander (10.1016/j.ijcchd.2025.100600_bib10) 2021; 80 |
References_xml | – volume: 103 start-page: 741 year: 2024 Apr end-page: 750 ident: bib5 article-title: Right disc thrombosis of the new gore cardioform ASD occluder publication-title: Cathet Cardiovasc Interv – volume: 63 start-page: 155 year: 1992 end-page: 162 ident: bib8 article-title: Pathways of coagulation activation in situ in rheumatoid synovial tissue publication-title: Clin Immunol Immunopathol – volume: 33 start-page: 297 year: 2014 end-page: 304 ident: bib7 article-title: Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis publication-title: Clin Rheumatol – volume: 80 start-page: 169 year: 2021 end-page: 175 ident: bib10 article-title: Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden publication-title: Ann Rheum Dis – volume: 27 start-page: 846 year: 2009 end-page: 855 ident: bib9 article-title: Rheumatoid arthritis and thrombosis publication-title: Clin Exp Rheumatol – volume: 43 start-page: 302 year: 2004 end-page: 309 ident: bib2 article-title: Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients publication-title: J Am Coll Cardiol – volume: 82 start-page: 1123 year: 2013 end-page: 1138 ident: bib1 article-title: Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies publication-title: Cathet Cardiovasc Interv – volume: 99 start-page: 1161 year: 2022 end-page: 1164 ident: bib3 article-title: GORE Cardioform ASD device thrombus weeks after COVI-19 infection publication-title: Cathet Cardiovasc Interv – volume: 95 start-page: 1285 year: 2020 end-page: 1295 ident: bib4 article-title: ASSURED Investigators. ASSURED clinical study: new GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect publication-title: Cathet Cardiovasc Interv – volume: 73 start-page: 1774 year: 2014 end-page: 1780 ident: bib6 article-title: Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study publication-title: Ann Rheum Dis – volume: 33 start-page: 297 year: 2014 ident: 10.1016/j.ijcchd.2025.100600_bib7 article-title: Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis publication-title: Clin Rheumatol doi: 10.1007/s10067-014-2492-7 – volume: 27 start-page: 846 year: 2009 ident: 10.1016/j.ijcchd.2025.100600_bib9 article-title: Rheumatoid arthritis and thrombosis publication-title: Clin Exp Rheumatol – volume: 73 start-page: 1774 year: 2014 ident: 10.1016/j.ijcchd.2025.100600_bib6 article-title: Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-203380 – volume: 103 start-page: 741 issue: 5 year: 2024 ident: 10.1016/j.ijcchd.2025.100600_bib5 article-title: Right disc thrombosis of the new gore cardioform ASD occluder publication-title: Cathet Cardiovasc Interv doi: 10.1002/ccd.31002 – volume: 99 start-page: 1161 year: 2022 ident: 10.1016/j.ijcchd.2025.100600_bib3 article-title: GORE Cardioform ASD device thrombus weeks after COVI-19 infection publication-title: Cathet Cardiovasc Interv doi: 10.1002/ccd.30067 – volume: 63 start-page: 155 year: 1992 ident: 10.1016/j.ijcchd.2025.100600_bib8 article-title: Pathways of coagulation activation in situ in rheumatoid synovial tissue publication-title: Clin Immunol Immunopathol doi: 10.1016/0090-1229(92)90008-C – volume: 80 start-page: 169 year: 2021 ident: 10.1016/j.ijcchd.2025.100600_bib10 article-title: Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2020-218419 – volume: 43 start-page: 302 year: 2004 ident: 10.1016/j.ijcchd.2025.100600_bib2 article-title: Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2003.10.030 – volume: 82 start-page: 1123 year: 2013 ident: 10.1016/j.ijcchd.2025.100600_bib1 article-title: Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies publication-title: Cathet Cardiovasc Interv doi: 10.1002/ccd.24875 – volume: 95 start-page: 1285 year: 2020 ident: 10.1016/j.ijcchd.2025.100600_bib4 article-title: ASSURED Investigators. ASSURED clinical study: new GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect publication-title: Cathet Cardiovasc Interv doi: 10.1002/ccd.28728 |
SSID | ssj0002810051 |
Score | 2.3021634 |
Snippet | A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial... AbstractA 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum... |
SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 100600 |
SubjectTerms | Atrial septal defect Cardiovascular Case Report Congenital heart disease GORE cardioform ASD occluder Rheumatoid arthritis Thrombus formation |
Title | GORE® CARDIOFORM ASD occluder thrombus in a patient of rheumatoid arthritis occurred three days after deployment |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2666668525000369 https://www.clinicalkey.es/playcontent/1-s2.0-S2666668525000369 https://dx.doi.org/10.1016/j.ijcchd.2025.100600 https://www.ncbi.nlm.nih.gov/pubmed/40698378 https://www.proquest.com/docview/3232490058 https://pubmed.ncbi.nlm.nih.gov/PMC12281148 https://doaj.org/article/6ce5d5f99da748dbb5554169d66ea5d9 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQCArhURmp14h1Nnbs49IHBalUaovUm-XYY21WkMBmc-if6o_gl-FxkioLSO2he4o2mTzG48w3zsw3hOxnDDzyjKUgATBAQcpbOU8Laxzj1uYFx9rh06_i5Fv-5YpfTVp9YU5YTw_cK-6DsMAd90o5U-TSlSUPDpAJ5YQAw10s3Qs-bxJMreKSEUNzG2vlYkJXtbJ2ieSgGcfcAIFFbRNfFCn7t1zSv5Dz78zJiSs6fkqeDBiSLvp7f0YeQf2c_Pp0dn70-4YeLM4PP5-F2O6ULi4OaWPt987BmmI_hB9l19KqpoYOdKq08XS9hC7A1qZyNGhjGUmOUAyJmxyKAVBnrlsa24lTB9giGNcUX5DL46PLg5N06KeQWi7VJjXGOCUy73iIEjJrpc-FkRBCQGsVFtGWRWZyp1wO3pQ-ICcvGCtZ2PIyy-e7ZKduanhFaO7dTIIvmVQ2B-vlTGWFFzM1D8LGFglJR8Xqnz1rhh7TyVa6HwiNA6H7gUjIR9T-7bHIeR3_CJagB0vQd1lCQvg4dnosKw0vwnCi6o6LF_-Tg3aYza1mus30TF8EMBN-Er8EI4-PmkoOgKUHIve45vvRuHSYz_iRxtTQdK2eI8RV2O0xIS97Y7tVC1YpYwOAhMgtM9zS2_aeulpGznCWhSkRQt_XD6HpN-QxPkufaveW7GzWHbwL2GxT7sVpuBcXzf4A1AY6rQ |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GORE%C2%AE+CARDIOFORM+ASD+occluder+thrombus+in+a+patient+of+rheumatoid+arthritis+occurred+three+days+after+deployment&rft.jtitle=International+journal+of+cardiology+congenital+heart+disease&rft.au=Nakagawa%2C+Naomi&rft.au=Shigemitsu%2C+Yusuke&rft.au=Okamoto%2C+Kengo&rft.date=2025-09-01&rft.pub=Elsevier&rft.eissn=2666-6685&rft.volume=21&rft_id=info:doi/10.1016%2Fj.ijcchd.2025.100600&rft.externalDocID=PMC12281148 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F26666685%2Fcov200h.gif |